192 related articles for article (PubMed ID: 33610396)
1. Clinical and pathological diagnosis and comparison of benign and malignant eyelid tumors.
Sendul SY; Akpolat C; Yilmaz Z; Eryilmaz OT; Guven D; Kabukcuoglu F
J Fr Ophtalmol; 2021 Apr; 44(4):537-543. PubMed ID: 33610396
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Clinical Characteristics and Outcome of Benign and Malignant Eyelid Tumors: An Analysis of 4521 Eyelid Tumors in a Tertiary Medical Center.
Huang YY; Liang WY; Tsai CC; Kao SC; Yu WK; Kau HC; Liu CJ
Biomed Res Int; 2015; 2015():453091. PubMed ID: 26634208
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological characteristics of malignant eyelid tumors at a referral hospital in Japan.
Goto H; Yamakawa N; Komatsu H; Asakage M; Tsubota K; Ueda SI; Nemoto R; Shibata M; Umazume K; Usui Y; Mori H
Jpn J Ophthalmol; 2022 Jul; 66(4):343-349. PubMed ID: 35670924
[TBL] [Abstract][Full Text] [Related]
4. Malignant eyelid tumours in Taiwan.
Wang JK; Liao SL; Jou JR; Lai PC; Kao SC; Hou PK; Chen MS
Eye (Lond); 2003 Mar; 17(2):216-20. PubMed ID: 12640409
[TBL] [Abstract][Full Text] [Related]
5. Eyelid tumors: clinical data from an eye center in Ankara, Turkey.
Gundogan FC; Yolcu U; Tas A; Sahin OF; Uzun S; Cermik H; Ozaydin S; Ilhan A; Altun S; Ozturk M; Sahin F; Erdem U
Asian Pac J Cancer Prev; 2015; 16(10):4265-9. PubMed ID: 26028084
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of eyelid lesions in Sri Lanka.
Nanayakkara DPS; Dissanayake MM; Gunaratne MP; Soysa VK; Mathangasinghe Y
Int Ophthalmol; 2023 Jul; 43(7):2513-2519. PubMed ID: 36881193
[TBL] [Abstract][Full Text] [Related]
7. Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience.
Ho M; Liu DT; Chong KK; Ng HK; Lam DS
Hong Kong Med J; 2013 Apr; 19(2):150-5. PubMed ID: 23535675
[TBL] [Abstract][Full Text] [Related]
8. Eyelid tumors in Siriraj Hospital from 2000-2004.
Pornpanich K; Chindasub P
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S11-4. PubMed ID: 16681045
[TBL] [Abstract][Full Text] [Related]
9. Eyelid Tumors at the University Eye Clinic of Ioannina, Greece: A 30-year Retrospective Study.
Asproudis I; Sotiropoulos G; Gartzios C; Raggos V; Papoudou-Bai A; Ntountas I; Katsanos A; Tatsioni A
Middle East Afr J Ophthalmol; 2015; 22(2):230-2. PubMed ID: 25949083
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of clinical diagnosis of cutaneous eyelid lesions.
Kersten RC; Ewing-Chow D; Kulwin DR; Gallon M
Ophthalmology; 1997 Mar; 104(3):479-84. PubMed ID: 9082276
[TBL] [Abstract][Full Text] [Related]
11. [Incidence of benign and malignant lesions of eyelid and conjunctival tumors].
Obata H; Aoki Y; Kubota S; Kanai N; Tsuru T
Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):573-9. PubMed ID: 16218435
[TBL] [Abstract][Full Text] [Related]
12. Eyelid masses: a 10-year survey from a tertiary eye hospital in Tehran.
Bagheri A; Tavakoli M; Kanaani A; Zavareh RB; Esfandiari H; Aletaha M; Salour H
Middle East Afr J Ophthalmol; 2013; 20(3):187-92. PubMed ID: 24014978
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of 2228 cases with eyelid tumors.
Yu SS; Zhao Y; Zhao H; Lin JY; Tang X
Int J Ophthalmol; 2018; 11(11):1835-1841. PubMed ID: 30450316
[TBL] [Abstract][Full Text] [Related]
14. The spectrum and clinicopathological correlation of eyelid lesions: Twenty years' experience at a tertiary eye care center in South India.
Banerjee P; Koka K; Alam MS; Subramanian N; Biswas J; Krishnakumar S; Mukherjee B
Indian J Ophthalmol; 2022 Jan; 70(1):43-50. PubMed ID: 34937206
[TBL] [Abstract][Full Text] [Related]
15. Profile of eyelid malignancy in a Tertiary Health Care Center in North India.
Gupta P; Gupta RC; Khan L
J Cancer Res Ther; 2017; 13(3):484-486. PubMed ID: 28862213
[TBL] [Abstract][Full Text] [Related]
16. Demographic features and histopathological diagnosis in primary eyelid tumors: results over 19 years from a tertiary center in Ankara, Turkey.
Eren MA; Gündüz AK
Int J Ophthalmol; 2020; 13(8):1287-1293. PubMed ID: 32821684
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.
Cook BE; Bartley GB
Ophthalmology; 1999 Apr; 106(4):746-50. PubMed ID: 10201597
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Demographic Features of Eyelid Lesions.
Fazil K; Karslioglu S; Akbaba M; Buttanri IB; Serin D; Karabulut GO; Bektasoglu D
Beyoglu Eye J; 2020; 5(2):114-117. PubMed ID: 35098073
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical characteristics of benign and malignant eyelid lesions: an analysis of 1423 eyelid lesions, compared between ophthalmology department and plastics department.
Levinkron O; Schwalb L; Shoufani A; Gutovitz J; Krausz J; Briscoe D
Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):615-621. PubMed ID: 37782346
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of malignant eyelid tumors.
Gniesmer S; Sonntag SR; Schiemenz C; Ranjbar M; Heindl LM; Varde MA; Emmert S; Grisanti S; Kakkassery V
Ophthalmologie; 2024 Jan; 121(Suppl 1):33-39. PubMed ID: 37851118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
